Amneal Pharmaceuticals, Inc. company logo
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) Cash From Financing

Annual CFF

-$211.72M$161.56M-322.11%

Summary

Current Value
As of today, AMRX annual cash from financing is -$211.72M, down -322.11% on
Historical Performance
AMRX annual cash from financing is down -53.28% over the past 3 years, and down -400.64% over the past 5 years
All-Time High Comparison
AMRX annual cash from financing is currently -140.61% below its historical high of $521.39M set on
3-Year Low Comparison
AMRX annual cash from financing is at its 3-year low
Sector Comparison
AMRX annual cash from financing is higher than 8.22% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AMRX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$211.72M-322.1%-53.3%-400.6%-2700.2%
Quarterly Cash From Financing$59.44M+164.4%+228.8%+616.5%+5221.7%
TTM Cash From Financing-$82.54M+7.8%+28.1%-159.3%-516.6%
Price$13.26+68.5%+500.0%+167.3%
Annual Cash From Operations$295.03M+61.1%+22.0%+10000.0%+3716.9%
Annual Cash From Investing-$63.00M+8.9%+67.6%-172.4%-189.1%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$2.59B-5.7%-9.8%-6.3%+100.0%
Shares Outstanding314.36M+1.4%+107.5%+112.9%

Cash From Financing Highs

AMRX Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y-$50.16M-322.1%
5Y$135.11MN/A-256.7%
All$521.39M-140.6%

Cash From Financing Lows

AMRX Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$211.72Mat low
5Y-$211.72Mat low
All-$211.72Mat low

Cash From Financing History

YearValueChange
-$211.72M-322.1%
-$50.16M+51.4%
-$103.24M+25.3%
-$138.12M-202.2%
$135.11M+419.5%
-$42.29M-114.1%
YearValueChange
$299.45M+415.2%
-$95.02M-124.3%
$391.78M-24.9%
$521.39M+3,517.2%
$14.41M-

FAQ

  • What is the current annual cash from financing of AMRX?

    As of today, AMRX annual cash from financing is -$211.72M

  • What is 1-year change in AMRX annual cash from financing?

    AMRX annual cash from financing is down -322.11% year-over-year

  • What is 3-year change in AMRX annual cash from financing?

    AMRX annual cash from financing is down -53.28% over the past 3 years

  • How far is AMRX annual cash from financing from its all-time high?

    AMRX annual cash from financing is currently -140.61% below its historical high of $521.39M set on December 1, 2015

  • How does AMRX annual cash from financing rank versus sector peers?

    AMRX annual cash from financing is higher than 8.22% of companies in Healthcare sector

  • When is AMRX next annual earnings release?

    The next annual earnings release for AMRX is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. AMRX Official Website www.amneal.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
  4. AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
  5. AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx